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Abstract
Background: Although the mitotic arrest deficient protein MAD2B (MAD2L2) is thought to inhibit the anaphase promoting
complex (APC) by binding to CDC20 and/or CDH1 (FZR1), its exact role in cell cycle control still remains to be established.
Methodology/Principal Findings: Using a yeast two-hybrid interaction trap we identified the human clathrin light chain A
(CLTA) as a novel MAD2B binding protein. A direct interaction was established in mammalian cells via GST pull-down and
endogenous co-immunoprecipitation during the G2/M phase of the cell cycle. Through subsequent confocal laser scanning
microscopy we found that MAD2B and CLTA co-localize at the mitotic spindle. Clathrin forms a trimeric structure, i.e., the
clathrin triskelion, consisting of three heavy chains (CLTC), each with an associated light chain. This clathrin structure has
previously been shown to be required for the function of the mitotic spindle through stabilization of kinetochore fibers. Upon
siRNA-mediatedMAD2Bdepletion,wefoundthatCLTAwasnolongerconcentratedatthemitoticspindlebut,instead,diffusely
distributed throughout the cell. In addition, we found a marked increase in the percentage of misaligned chromosomes.
Conclusions/Significance: Previously, we identified MAD2B as an interactor of the renal cell carcinoma (RCC)-associated
protein PRCC. In addition, we found that fusion of PRCC with the transcription factor TFE3 in t(X;1)(p11;q21)-positive RCCs
results in an impairment of this interaction and a concomitant failure to shuttle MAD2B to the nucleus. Our current data
show that MAD2B interacts with CLTA during the G2/M phase of the cell cycle and that depletion of MAD2B leads to a
marked increase in the percentage of misaligned chromosomes and a redistribution of CLTA during mitosis.
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Introduction
The mitotic arrest deficient protein MAD2B (MAD2L2) is a
member of a MAD family of proteins and shows 48% similarity to
MAD2 (MAD2L1) [1,2]. Both MAD2 and MAD2B can bind to the
anaphase promoting complex or cyclosome (APC/C), which is a
downstream target of the mitotic spindle checkpoint. APC/C is
activated by CDC20 and/or CDH1 (FZR1), whereas MAD2 and
MAD2B canactasAPC/CinhibitorsbybindingtoCDC20and/or
CDH1, respectively [3,4]. More recently, it was found that during
mitosis clathrin is localized to kinetochore fibres of the spindle [5].
Clathrin is composed of heavy (CLTC) and light (CLTA/CLTB)
chains, respectively, and direct binding of clathrin to the
kinetochore fibres is thought to be mediated by the heavy chain,
since in the absence of CLTC, clathrin light chains are no longer
recruited to the spindle [5]. Once bound to the mitotic spindle
apparatus, clathrin stabilizes mitotic microtubules by forming a
trimeric structure, i.e., the clathrin triskelion [6]. RNAi-mediated
knock down ofCLTCleadstokinetochorefiberde-stabilization and
concomitant defective congression of chromosomes to the meta-
phase plate and persistent activation of the spindle checkpoint.
Normally,MAD2 islocalized tokinetochoresinearlyprometaphase
and becomes diffusely distributed in metaphase. Since in CLTC
depleted cells MAD2 was found to be located at the kinetochores of
both misaligned chromosomes and chromosomes at the metaphase
plate, it was concluded that the persistent spindle checkpoint
activation may be mediated by MAD2 signalling [5]. Together,
these observations suggest that clathrin may act as an integral
component of the mitotic spindle apparatus and that its abrogation
may lead to chromosomal instability and, ultimately, cancer [7–9].
Interestingly,fusions ofCLTCwiththe anaplastic lymphomakinase
(ALK) have been encountered in inflammatory myofibroblastic
tumors and anaplastic large-cell lymphomas [10], whereas fusions
with the transcription factor TFE3 have been encountered in renal
cell carcinomas (RCC) [11,12]. These fusions are expected to
disrupt clathrin trimerization, thereby impairing its function during
mitosis [5]. Previously, we found that in RCCs carrying a recurrent
t(X;1)(p11;q21) chromosome translocation TFE3 is fused to a novel
protein, PRCC [13,14]. Subsequently, we found that PRCC can
interact with MAD2B and, by doing so, mediate its shuttling to the
nucleus[15]. The PRCCTFE3 fusion protein, however, haslostthis
capacity in spite of the fact that the PRCC interaction domain is
retained in the fusion product. Based on these results, we previously
hypothesized that the putative role of MAD2B in cell cycle control
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(p11;q21)-positive RCCs [15]. To further assess this role, we
performed a yeast two-hybrid interaction screen with MAD2B as a
bait. By doing so, we identified the clathrin light chain CLTA as a
novel bona fide interactor.
Results
Identification of CLTA as a MAD2B binding protein
In order to further assess the role of MAD2B in cell cycle control,
we set out to identify binding proteins using a yeast two-hybrid
interaction trap (see Materials and methods). By employing the full
codingsequenceofMAD2BasbaitandahumantestiscDNAlibrary
as prey, we recovered 92 colonies that grew on fully selective SD
medium. Of these colonies, 87 turned blue in a LacZ filter lift assay
and 69 were selected for further analysis. The corresponding
plasmids were recovered and re-introduced into the same yeast cells
and, subsequently, these cells were plated in fully selective SD
medium and re-screened for b-galactosidase activity. These
combined assays yielded six independent plasmids, all encompassing
coding sequences for the clathrin light chain A (CLTA) protein.
Among these six clones, five clones contained full-length CLTA
coding sequences and one clone truncated sequences coding for its
C-terminal 100 amino acids. Co-transfection of these prey clones
with standard control plasmids encoding lamin-B and p53 turned
out to be negative, thereby validating the yeast two-hybrid
interactions observed. In order to refine the identification of a
specific domain of CLTA required for interacting with MAD2B, a
series of deletion constructs was generated lacking consecutive
stretches of 50 amino acids at either the C- or N-terminal regions of
the coding sequence (Fig. 1A). The resulting CLTA (deletion)
constructs were co-transfected with full-length MAD2B into yeast
cells and tested for their ability to grow on fully selective SD medium
and for b-galactosidase activity. The data obtained indicate that the
C-terminal region (containing amino acids 151–218) is required for
the MAD2B-CLTA interaction, since all C-terminal deletions of the
Figure 1. MAD2B and CLTA interact physically. (A) Schematic representation of the CLTA (deletion) constructs (numbers correspond to amino
acid positions) and corresponding interactions with MAD2B measured as OD420/OD600 ratios using a liquid b-galactosidase assay. (B) HA-MAD2B
protein was probed for interaction with either GST or GST-CLTA. Subsequent western blot analysis was performed using an anti-HA tag antibody. (C)
U2OS cells were transiently transfected with HA-MAD2B and FLAG-CLTA. Immunoprecipitations (IP) were performed with a control rabbit antibody
(IgG) and an anti-MAD2B antibody as indicated. Western blot analysis was performed using an anti-FLAG antibody. (D) U2OS cells were synchronized
by a double thymidine block (see Materials and methods) and subsequently harvested at different time intervals after release from this cell cycle
block. Immunoprecipitations were performed on cell lysates from unsynchronized cells and from cells at t=0 and t=12 after release. Endogenous
proteins were precipitated with an anti-CLTA and a control mouse antibody (IgG) as indicated. Western blot analysis was performed using anti-CLTA
and anti-MAD2B antibodies.
doi:10.1371/journal.pone.0015128.g001
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shown) and b-galactosidase activity (Fig. 1A). In addition, the central
domain of CLTA appears to be essential, but not sufficient, for
binding to the MAD2B protein. These observations are completely
in line with our initial yeast two-hybrid screening data. A reduction
of the critical interaction domain within the MAD2B protein could
not be attained, since all deletions, including N-terminal and C-
terminal deletions (see materials and methods), resulted in a
complete abolition of the MAD2B-CLTA interaction (data not
shown).
MAD2B and CLTA interact physically
To investigate whether the MAD2B protein physically interacts
with CLTA, we performed a glutathione S-transferase (GST) pull-
down assay. To this end, full length GST-CLTA fusion protein was
produced in E. coli cells, and full-length HA-tagged MAD2B (HA-
MAD2B) was expressed in U2OS cells. After pull down of the GST-
CLTA fusion protein, and GST as a control, the samples were
analyzed by western blotting using an anti-HA antibody. By doing
so, we found that the MAD2B protein (expected size, 28–29 kDa)
[3] was pulled down with the GST-CLTA fusion protein, but not
with GST alone (Fig. 1B), thus supporting a physical in vitro
interaction between MAD2B and CLTA. To further confirm this
interaction in vivo, U2OS cells were transiently transfected with HA-
MAD2B and FLAG-tagged CLTA (FLAG-CLTA) expression
constructs. Subsequently, immunoprecipitations were performed
on the double transfectants using an anti-MAD2B antibody to
precipitate MAD2B and/or HA-MAD2B. After western blotting
using an anti-FLAG antibody, the FLAG-CLTA protein could
readily be observed in the input and the anti-MAD2B immuno-
precipitate, but not in the mock (IgG) immunoprecipitate (Fig. 1C),
thus confirming the in vivo interaction between exogenous MAD2B
and CLTA in mammalian cells. Subsequently, the endogenous
interaction between MAD2B and CLTA was assessed. To this end,
U2OS cells were synchronized (double thymidine block, see
Materials and methods) and subsequently harvested at different
time points after release from this cell cycle block. Concomitant
FACS analyses (Fig. S1) revealed that the majority of unsynchro-
nized cells was in the G0 and/or G1 phase of the cell cycle and that
before release from the cell cycle block (t=0) the majority of cells
was in the S phase of the cell cycle, as expected. At 12 hours after
release from the cell cycle block (t=12) the majority of cells was in
the G2 and/or M phase. After protein extraction from these
respective samples, immunoprecipitations were carried out using an
anti-CLTAantibody.Subsequent westernblot analysiswith ananti-
MAD2B antibody readily revealed MAD2B protein in the CLTA
immunoprecipitate at t=12, but not in the other immunoprecip-
itation samples (i.e., unsynchronized and t=0; Fig. 1D), thereby
confirming an endogenous interaction of these two proteins,
primarily during the G2 and/or M phase of the cell cycle.
Since CLTA is known to form a complex with the clathrin
heavy chain (CLTC) during mitosis, i.e., the triskelion, we
investigated whether endogenous MAD2B can bind to this
complex. To this end, U2OS cells were grown in the presence
of
35S labeled methionine and, subsequently, whole cell lysates
were prepared and used for immunoprecipitation with an anti-
MAD2B, an anti-CLTA and a control IgG antibody. By doing so,
we observed a strong band of ,190 kDa (CLTC; Fig. S2A) after
immunoprecipitation with the anti-CLTA antibody, as expected
[9,16]. This same band was also observed after immunoprecip-
itation with the anti-MAD2B antibody, but not with the control
IgG antibody, thus indicating that endogenous MAD2B can
indeed bind to the CLTA-CLTC complex, presumably in its
triskelion configuration.
MAD2B and CLTA co-localize at the mitotic spindle
In order to further assess the observed interaction between
MAD2B and CLTA in mammalian cells, expression constructs
carrying full-lengthcoding sequencesofmRFP-tagged MAD2B and
GFP-tagged CLTA were transiently transfected into U2OS cells.
After confocal laser scanning microscopy, we found that MAD2B
exhibited a diffuse staining pattern in both the cytoplasm and the
nucleus (Fig. 2, upper panels), as expected [15,17]. Also as expected
[5,18], CLTA showed a punctate membranous/cytoplasmic
distribution with an accumulation at the Golgi apparatus (Fig. 2,
upper panels). CLTA was not observed within the nucleus during
interphase. Accordingly, CLTA and MAD2B failed to show any
overt sub-cellular co-localization during interphase. In order to
assess the sub-cellular localization of both proteins during mitosis,
U2OS cells were again synchronized with a double thymidine block
(see above) and fixed at different time intervals after release. By
doing so, we found that during mitosis CLTA was located at the
mitotic spindle co-localizing with a-tubulin (Fig. S3). MAD2B
exhibited a very similar localization at the mitotic spindle, and the
overlay of both corresponding fluorescent signals revealed a perfect
co-localization (Fig. 2, lower panels, yellow staining), thus fully
corroborating the above protein-protein interaction data.
Cellular re-distribution of CLTA and chromosomal
misalignment after MAD2B knockdown
Having established that MAD2B and CLTA interact and co-
localize at the spindle during mitosis, we next questioned what the
effect on the sub-cellular localization of these proteins would be after
depletion. To this end, we generated a stable MAD2B siRNA-
inducible HEK293 cell line (see Materials and methods) in which,
after 4 days of tetracyclin induction, the amount of MAD2B protein
was reduced to 2% (Fig. 3A). Both non-depleted and MAD2B-
depleted cells were fixed, incubated with an anti-CLTA antibody
and analyzed byimmunofluorescence. In accordance with the above
exogenous expression data, we found that in the non-depleted cells
endogenous CLTA also exhibited a punctuated cytoplasmic staining
pattern with a perinuclear (Golgi) accumulation during interphase
(Fig. 3B, upper panels). In MAD2B-depleted cells a similar pattern
was observed (not shown). During mitosis endogenous CLTA was,
again in accordance with the above exogenous expression data,
localized at the mitotic spindle (Fig. 3B, middle panels). In contrast,
however, we found that in the MAD2B-depleted cells endogenous
CLTA no longer localized at the mitotic spindle but, instead, was re-
distributed diffusely throughout the cell (Fig. 3B, lower panels). The
endogenous localization of CLTC was unaffected in these cells (Fig.
S2B). In order to assess the effect of MAD2B depletion on an orderly
mitotic progression, we systematically analyzed mitotic figures from
HEK293/T-REx MAD2B knock down cells (+MAD2B siRNA)
using live cell imaging and compared these with those similarly
obtained from wild-type HEK293/T-REx cells (- MAD2B siRNA).
By doing so, we observed a significant overall increase (34.65%
versus 11.65%, T-test, p=0.030) in misaligned chromosomes in the
knock down cells (Table S1), including centrophilic chromosomes,
anaphase bridges and lagging chromosomes (Fig. 4; indicated by
arrows in left, middle and right panels, respectively). A marked
increase in chromosome aberrations after siRNA-mediated knock
down of MAD2B has also been reported by Cheung et al. [19] in
nasopharyngeal carcinoma cells in response to DNA damage, thus
corroborating the results obtained here.
In order to assess whether exogenous expression of PRCCTFE3,
whichfailstoshuttleMAD2Btothenucleus[15],hasasimilareffect
on mitotic progression as siRNA-mediated MAD2B depletion, we
systematically analyzed mitotic figures from induced HEK293/T-
REx PRCCTFE3 cells (+PRCCTFE3) and compared these with
MAD2B Interacts with Clathrin Light Chain A
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PRCCTFE3 cells (- PRCCTFE3). Also here, a significant overall
increase (78.22% versus 30.10%, T-test, p=0.024) in misaligned
chromosomes was observed in the induced versus un-induced cells
including, again, centrophilic chromosomes, anaphase bridges and
lagging chromosomes (Fig. 5; Table S2).
Discussion
Using a yeast two-hybrid-based interaction trap with MAD2B as
a bait we identified the human clathrin light chain A (CLTA) as a
novel bona fide interactor. The interaction was subsequently
confirmed in mammalian cells using both in vitro and in vivo assays,
and the interaction interface could be narrowed down to two
domains, i.e., a C-terminal and a central domain. Previously, the
CLTA C-terminal domain was found to function as a calmodulin-
binding domain, whereas the central domain was found to function
as a clathrin heavy chain (CLTC) binding domain [9]. This CLTC
binding domain, in turn, was found to be essential for the formation
of the clathrin trimeric structure, i.e., the clathrin triskelion [6]. It
has been reported that the C-terminus of CLTA can also interact
with the trimerization domain of the clathrin triskelion structure.
We found that endogenous CLTC co-immunoprcipitates with
MAD2B, suggesting that MAD2B may bind to clathrin in its
triskelion conformation. Since our results additionally showed that
full-length MAD2B protein is required for maintaining the
interaction with CLTA, this interaction appears to be dependent
on a proper folding of the protein and/or a proper exposure of its
interaction interface(s) such as the HORMA domain [2,20].
Additional evidence suggests that MAD2B may form multimeric
configurations, a feature that has been extensively documented for
the various protein-protein interactions exhibited by its closely
related homolog MAD2 [21,22]. Clathrin is similarly known to
form multimeric lattices during clathrin-mediated membrane
trafficking (i.e., coated vesicles) in interphase cells [23]. More
recently it was discovered that clathrin may also play an important
role in the mitotic spindle checkpoint [5]. Through gene trapping of
nuclear proteins [24] and mass spectrometry of purified mitotic
spindles [25] it has been established that clathrin is an integral
component of the mitotic spindle. Using GFP-tagged clathrin light
[18] and heavy [5] chains it was found that both subunits are
recruited to microtubules as these invade the nuclear lamina during
early prophase. Subsequently, clathrin remains associated with the
spindle microtubules throughout chromosome congression, meta-
phase and chromosome segregation during anaphase. Only during
telophase, clathrin is dissociated, followed by a re-establishment of
clathrin proteinsintheGolgi apparatus. Usingimmunofluorescence
(electron) microscopy, it was found that clathrin is intimately
associated with kinetochore fibers, bundles of microtubules that
connect the spindle pole to the kinetochores of chromosomes [5].
When CLTC was depleted from the cells a number of mitotic
defects was encountered, including misaligned chromosomes, such
Figure 2. MAD2B and CLTA co-localize at the mitotic spindle. Cells were transiently transfected with CLTA-GFP (green) and MAD2B-mRFP
(red) constructs. DAPI staining (blue) marks the position of the nuclei and chromosomes. Yellow staining in the overlay indicates co-localization of
MAD2B and CLTA. The upper two panels show cells in interphase, the lower two panels show cells in mitosis.
doi:10.1371/journal.pone.0015128.g002
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These defects were found to result in prolongation of mitosis due to
continued signaling of the mitotic spindle checkpoint, presumably
through MAD2 [5]. Since the N-terminal domain of CLTC binds
to the spindle, it has been suggested that clathrin may actas a bridge
between two or three microtubules within a spindle fiber to increase
its stability [5].
MAD2B is, like its closely related homolog MAD2, a member of
the MAD family of proteins [1,2]. Whereas the role of MAD2 in
mitotic spindle checkpoint control is well-documented, the exact
role of MAD2B still remains to be established. We found that
MAD2B physically interacts and co-localizes with CLTA at the
mitotic spindle and that depletion of MAD2B from the cells leads
to a redistribution of CLTA and a concomitant occurrence of
Figure 3. Cellular re-distribution of CLTA after MAD2B knockdown. (A) HEK293/T-REx cells were stably transfected with a pSUPERIOR-
MAD2B siRNA construct (see Materials and methods). Subsequently, tetracyclin was added and cells were collected after 0, 1, 2 and 4 days, lysed and
subjected to western blot analysis using anti-MAD2B and anti-c-tubulin (control) antibodies. (B) HEK293/T-REx/pSUPERIOR-MAD2B cells were grown
with or without tetracyclin (+/2 MAD2B siRNA, respectively). Endogenous CLTA proteins were detected using an anti-CLTA antibody (green). DAPI
staining (blue) was used to mark nuclei and chromosomes. In the presence of MAD2B CLTA localizes to mitotic spindles during mitosis, whereas after
MAD2B depletion CLTA is re-distributed throughout the cell.
doi:10.1371/journal.pone.0015128.g003
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depletion the localization of CLTC to the mitotic spindle was
unaffected. This latter observation is completely in line with data
indicating that the determinant for spindle binding is contained
within the heavy chain [5]. Based on our observations and those
reported by others, we conclude that the MAD2B-CLTA
interaction may be functional and, as such, may play a role in
the control of an orderly mitotic progression. Whether a functional
loss of this interaction induces destabilization of kinetochore fibres
and a concomitant continued signalling of the mitotic spindle
checkpoint still remains to be established.
Clathrin has been considered to be a ‘moonlighting protein’
which acts during interphase in membrane trafficking and during
mitosis in stabilizing spindle fibers [9]. Other examples of such
proteins include NUP107, NUP133 [26], NUP358 [27] and
RANGAP1 [28]. These proteins are involved in nuclear transport
during interphase and localize to kinetochores on the mitotic
spindle during mitosis to ensure orderly mitotic progression [27].
Until recently, it was unclear which molecule(s) might recruit
clathrin to the mitotic spindle. Yamauchi et al. [29]. reported that
a B-MYB complex may ferry clathrin to the mitotic spindle Our
results suggest that MAD2B may act to ferry the clathrin light
Figure 4. MAD2B depletion leads to mitotic defects. HEK293/T-REx/pSUPERIOR-MAD2B cells were transiently transfected with a H2B-RFP
construct (see Materials and methods) and grown with or without tetracyclin (+/2 MAD2B siRNA), respectively. Subsequently, mitotic cells were
scored for misaligned chromosomes. Percentages of cells with misalignments, such as centrophilic chromosomes, anaphase bridges and lagging
chromosomes, are shown in the histogram. Black bars represent cells normally expressing MAD2B (- MAD2B siRNA; see Fig. 3, t=0), and white bars
represent MAD2B depleted cells (+MAD2B siRNA; see Fig. 3, t=4). In the lower panels examples of centrophilic chromosomes, anaphase bridges and
lagging chromosomes are shown (arrows).
doi:10.1371/journal.pone.0015128.g004
Figure 5. PRCCTFE3 expression leads to mitotic defects. HEK293/T-REx/PRCCTFE3 cells were transiently transfected with a H2B-RFP construct
(see Materials and methods) and grown with or without tetracyclin (+/2 PRCCTFE3), respectively. Subsequently, mitotic cells were scored for
misaligned chromosomes. Percentages of cells with misalignments, such as centrophilic chromosomes, anaphase bridges and lagging chromosomes,
are shown in the histogram. Black bars represent un-induced cells (- PRCCTFE3), and white bars represent induced cells (+PRCCTFE3). In the right
panel, PRCCTFE3 protein expression in the induced (+ tetracyclin) cells is shown.
doi:10.1371/journal.pone.0015128.g005
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renal cell carcinomas expressing a PRCCTFE3 fusion protein this
function may be abrogated through an impairment of the PRCC-
MAD2B interaction and a concomitant failure to shuttle MAD2B
to the nucleus [15]. Accordingly, our preliminary data show that
exogenous expression of PRCCTFE3 has a deleterious effect on
orderly mitotic progression reminiscent of that observed after
siRNA enforced MAD2B depletion. Teleologically, this anomaly
may contribute to tumor development analogous to what has been
suggested for CLTC fusions with ALK in inflammatory myofi-
broblastic tumors and anaplastic large-cell lymphomas [10], and
with TFE3 in renal cell carcinomas [11,12]. Also these latter
fusions are thought to disrupt clathrin trimerization, thereby
impairing its function during mitosis [5].
Materials and Methods
Yeast two-hybrid assays
Yeast two-hybrid assays were performed essentially as described
before using a hybriZAP human testis cDNA library containing
approximately 4610
6 independent cDNA clones with an average
insert size of ,1 kb [15,30]. Of these, 1610
6 clones were amplified
once and 1610
9 of the resulting plaque forming units were mass-
excised according to the manufacturer’s instructions to generate an
interaction cDNA library in pAD-GAL4. The yeast strain used for
the interaction assays was pJ69-4A (a kind gift from Philip James).
Positive interactions in this yeast strain can be selected for by
adenine and histidine auxotrophy, next to b-galactosidase activity.
The pJ69-4A strain was co-transfected with bait plasmid pBDT3C,
carrying the human MAD2B coding sequence (AL031731), and the
testis cDNA library using the Yeastmaker transformation kit
(Clonetech). To select double transfectants, containing a pBD and
a pAD vector, the transfected yeast cells were plated on synthetic
defined (SD) medium lacking leucine and tryptophan (-LW). All
resulting colonies were recovered from these plates, titrated, and re-
plated on SD medium lacking histidine, adenine, leucine and
tryptophane (-HALW) to reselect yeast clones expressing MAD2B
interacting proteins. Colonies were allowed to grow for at least 5
days at 30uC after which replicate filters were lifted and tested for b-
galactosidase activity according to the manufacturer’s instructions
(LacZ filter lift assay; Stratagene). The cDNA inserts of positive
clones were isolated by direct PCR on yeast colonies with two pAD-
GAL4 specific oligonucleotides, pAD-for (CTGTCACCTGGTT-
GGACGGACCAA) and pGAD-rev (GTGAACTTGCGGGGTT-
TTTCAG). All resulting PCR products were sequenced using the
same oligonucleotides, and the pAD plasmids of these yeast clones
were rescued in DH5a bacteria. Finally, the interacting cDNA
clones were retransformed together with control plasmids as
reported before [30]. Interactions were quantified by both a liquid
b-galactosidase assay, using o-nitrophenyl-b-D-galactopyranoside
(ONPG) as a substrate [31], and a liquid growth assay. To this end,
pJ69-4A yeast cells were co-transfected with pAD plasmids carrying
different CLTA (deletion) constructs (Fig. 1A) and the MAD2B bait
plasmid. These co-transfectants were plated on SD-LW plates and
incubated at 30uC for 3 days, after which three independent
colonies were picked and grown to a stationary state in 5 ml of SD-
LW medium (2 days at 30uC). Of these cultures, 15 ml was used to
inoculate15 mlofSD-HLWmedium.Duringsubsequentgrowthat
30uC the OD600 was monitored and, at the mid-log phase, the
mmax was determined: mmax=[ln(xt) – ln(x0)]/t, where xt is the
OD600 of the culture at t=t, x0 is the OD600 at t=0 and t is the
time between x0 and xt. The interaction scores for each CLTA
deletion construct were expressed as means of three independent
clones.
Cloning and sequencing procedures
All cloning procedures were essentially as described before
[17,30,32]. Sequence analyses were performed at the DNA
sequence facility of the Radboud University Nijmegen Medical
Centerusinga 3730DNAAnalyzer(Applied Biosystems).DNAand
protein databases were searched using the BLAST or BLAT search
algorithms at the NCBI or UCSC, respectively. Deletion constructs
of human CLTA were generated by using 27–28 nt primers
dispersed at intervals of 150 nt throughout the cDNA sequence.
The 59-end of the forward primers used were located at amino acid
positions 1, 51,101 and 151, respectively, accordingto BC_009201.
The reverse primers were located at positions 218, 167 and 117.
Deletion constructs of human MAD2B were generated using
primers dispersed at intervals of 150 nt throughout the cDNA
sequence as reported before [17]. The resulting PCR products were
cloned into pGEM-T (Promega), sequence-verified, and subcloned
into the correct pBDT3C and pGADT3C vectors.
Cell culture
U2OS cells were cultured in DMEM (Invitrogen) supplemented
with 10% FCS, penicillin (100 U/ml) and streptomycin (100 mg/
ml) at 37uC and 7.5% CO2. HEK293/T-REx cells were cultured in
DMEM supplemented with blasticidin (5 mg/ml), penicillin
(100 U/ml) and streptomycin (100 mg/ml). HEK293/T-REx/
PRCCTFE3 cells [15] were cultured in DMEM, supplemented
with 10% FCS, zeocin (500 mg/ml), blasticidin (5 mg/ml), penicillin
(100 units/ml) and streptomycin (100 mg/ml). For induction of
PRCCTFE3 expression, tetracyclin was added to the culture
medium (24 hours; 1 mg/ml). For the cellular localization studies,
full length MAD2B was cloned into pDEST733 (mRFP; Invitrogen)
and CLTA was cloned into pEGFP-N2 and pEGFP-C3 (Clontech).
Cells were transiently transfected using an Amaxa Nucleofector
according to the instructions of the manufacturer (Lonza). For
localization of the proteins, cells were fixed one day after
transfection for 30 min at room temperature with PBS containing
3.7% paraformaldehyde pH 7.4 and, subsequently, embedded in
Vectashield with DAPI (Vector Labs). Cells were then analyzed by
immunofluorescence and/or confocal laser scanning microscopy as
reported before [30]. For live cell imaging, cells were transiently
transfected with a histone 2B containing pTSIN- H2B-RFP
construct (a kind gift from Jan van Deursen) and scored for
chromosome misalignments during mitosis using a Zeiss Axiovert
200 M microscope. Cells were synchronized using a double
thymidine block (early S-phase block). To this end, cells were
incubated in DMEM supplemented with thymidine (2 mM) for
16 h, washed three times, incubated in complete DMEM without
thymidine and grown for another 8 h prior to a second incubation
with thymidine (2 mM) for 16 h. After release from this second
block, cells were grown in complete DMEM during several time
intervals. During these time intervals, cell cycle stages were
determined by FACS analysis as reported before [17,32,33]. For
35Smethioninelabelling,cellswereincubatedfor30 mininDMEM
minus methionine (Invitrogen) supplemented with 10% FCS,
penicillin (100 U/ml) and streptomycin (100 mg/ml) at 37uCa n d
7.5% CO2, followed by removal of the medium and addingDMEM
minus methionine supplemented with 10% FCS, penicillin (100 U/
ml), streptomycin (100 mg/ml) and 0.25 mCi
35S methionine. Cells
were incubated for 16 h at 37uC and 7.5% CO2 before harvesting.
GST pull-down and co-immunoprecipitation assays
The full length CLTA coding sequence was cloned into a
pDEST15 vector (Invitrogen) and transformed into BL21-DE3
cells (Promega), yielding a fusion protein with a GST tag at the N-
terminus (GST-CLTA). Purification of this fusion protein was
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length MAD2B coding sequence was cloned into a pDEST303
vector, yielding a HA-tagged MAD2B protein (HA-MAD2B) and
transfected into U2OS cells after sequence verification. For the
GST pull-down assays, 50 ml of GST-CLTA was combined with
100 ml of lysates from U2OS cells expressing HA-MAD2B. In
addition, 50 ml glutathione Sepharose 4B slurry (Amersham
Biosciences) was used. A protease inhibitor cocktail (Roche) was
added during all wash steps. Before use, the sepharose beads were
washed twice with TBS (25 mM Tris pH 7.4 and 150 mM NaCl),
followed by a 2 h incubation of the GST-CLTA (and GST alone
as a control) with the beads. After this incubation, the GST-
coupled beads were washed with TBSTD buffer (25 mM Tris
pH 7.4, 150 mM NaCl, 1.0% Triton X-100 and 2 mM DTT),
and incubated overnight at 4uC with lysates of U2OS cells
expressing HA-MAD2B (see above). After five additional washes
with lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl and
0.5% Triton X-100) and washing buffer (50 mM Tris-HCl
pH 7.5, 100 mM NaCl, 2 mM MgCl2, 2 mM CaCl2, 1% Triton
X-100 and 2 mM DTT) the samples were denatured and loaded
onto 4–12% NuPAGE polyacrylamide gels (Invitrogen). After
electrophoreses the gels were blotted onto nitrocellulose mem-
branes (Protran, Schleicher and Schuell). The resulting blots were
blocked in PBS with 5% non fat dry milk and incubated with anti-
MAD2B antibody for 1 h at room temperature and, subsequently,
with either a peroxidase conjugated secondary antibody (Zymed)
or a fluorescent conjugated secondary antibody (Molecular
Probes). Peroxidase signals were visualized using auto-radiograph-
ic exposure to Kodak X-Omat films, while fluorescent signals were
scanned and analyzed with the Odyssey system and its associated
software (Li-Cor). For immunoprecipitation studies, the full length
CLTA coding sequence was cloned into a pDEST306 vector,
yielding a FLAG-tagged CLTA protein (FLAG-CLTA) and
transfected into U2OS cells after sequence verification. Cells were
washed three times in ice-cold PBS and scraped from the tissue
culture dishes. Total cell lysates were prepared in 1 ml lysis buffer
(PBS,10% glycerol, 0.1% NP40, protease inhibitors), kept on ice
for 10 min while vortexed gently at 2 min intervals, and
centrifuged for 30 min at 38.500 rpm at 4uC. The supernatants
were pre-cleared in 100 ml of protein A/G PLUS Sepharose (50%
slurry in lysis buffer; Santa Cruz) for 1 h at 4uC and subsequently
centrifuged for 3 min at 2500 rpm at 4uC. Immunoprecipitations
were performed with these pre-cleared supernatants by adding 1–
5 mg primary antibody, followed by a 1 h rotation at 4uC.
Subsequently, 25 ml protein A/G PLUS Sepharose (50% slurry in
lysis buffer; Santa Cruz) was added to the immune complexes for
1 h at 4uC. The sepharose-bound immune complexes were
collected by centrifugation (3 min; 2500 rpm; 4uC) and the
resulting pellets were washed five times with lysis buffer before
antigens were released by heating at 95uC for 5 min. Western
blotting was performed as described above. For quantification of
western blot signals the ImageJ software tool was used (http://rsb.
info.nih.gov/ij/). The area under the curve (AUC) of a specific
signal was corrected by the AUC of the loading control. The
measurements of uninduced samples were arbitrarily set at 100%
and the other conditions were recalculated correspondingly,
thereby allowing ratio comparisons.
RNA interference assays
MAD2B-specific siRNA constructs were generated in a
pSUPERIOR vector (OligoEngine). To this end, the following
primers were used: forward GATCCCCCTGTGAGTTGTTT-
CAATAAttcaagagaTTA-TTGAAACAACTCACAGTTTTTGG-
AAA and reverse AGCTTTTCCAAAAACTGTGAGTTGTTT-
CAATA-AtctcttgaaTTATTGAAACAACTCACAGGGG. The
forward and reverse strands of oligo’s containing the MAD2B
siRNA-expressing sequence were annealed and subsequently
cloned into pSUPERIOR. Two days after transfection of this
construct into HEK293/T-REx cells, transfected cells were
selected using 2 mg/ml puromycin (Sigma Aldrich), expanded
and tested for MAD2B expression after tetracyclin induction.
Antibodies
A polyclonal rabbit anti-MAD2B antibody was used as
described before [15]. Monoclonal mouse anti-FLAG (Sigma),
monoclonal mouse anti-HA (Sigma), monoclonal mouse anti-c-
tubulin (Abcam), polyclonal rabbit anti-a-tubulin (Santa Cruz),
monoclonal mouse anti-CLTA (Sigma), polyclonal rabbit anti-
CLTA (Protein Tech Group) and monoclonal mouse anti-CLTC
(alias CHC; Abcam) antibodies were used according to the
instructions of the manufacturers.
Supporting Information
Figure S1 Synchronization of U2OS cells and cell cycle
distribution. U2OS cells were synchronized using a double
thymidine block (early S-phase block; see Materials and Methods)
and subsequently released during several time intervals (t=0 to
t=15 h). Concurrent cell cycle distributions were measured using
FACS analysis and expressed as percentages G0/G1, S and G2/
M cells, respectively [31;32].
(PDF)
Figure S2 CLTC localization is not affected by MAD2B
knockdown. (A) U2OS cells were grown in the presence of
35S-
labelled methionine. Subsequent immunoprecipitations were per-
formed on cell lysates using anti-CLTA, anti-MAD2B and control
(IgG) antibodies. CLTC marks the position of the clathrin heavy
chain. (B) HEK293/T-REx/pSUPERIOR-MAD2B cells were
grown in the presence of tetracyclin (+MAD2B siRNA). Endoge-
nous CLTC proteins were detected using an anti-CLTC antibody
(red). DAPI staining (blue) was used to mark nuclei and
chromosomes. CLTC localizes to the mitotic spindle during mitosis
after MAD2B depletion.
(PDF)
Figure S3 CLTA co-localizes with a-tubulin at the
mitotic spindle. U2OS cells were stained with anti-CLTA
(green) and anti-a-tubulin (red) antibodies. DAPI staining (blue)
marks the position of the chromosomes. Yellow staining in the
overlay indicates co-localization of endogenous CLTA and a-
tubulin at the mitotic spindle.
(PDF)
Table S1 Mitotic defects in HEK293/T-REx after
MAD2B depletion. HEK293/T-REx/pSUPERIOR-MAD2B
cells were transiently transfected with a H2B-RFP construct (see
Materials and methods) and grown with or without of tetracyclin
(+/2 MAD2B siRNA), respectively. Subsequently, cells were live
recorded and scored for chromosome misalignments during
mitosis. Numbers (#) and percentages (%) of cells with
misalignments, such as centrophilic chromosomes, anaphase
bridges and lagging chromosomes are listed.
(DOC)
Table S2 Mitotic defects in HEK293/T-REx after
PRCCTFE3 induction. HEK293/T-REx/PRCCTFE3 cells
were transiently transfected with a H2B-RFP construct (see
Materials and methods) and grown with or without of tetracyclin
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recorded and scored for chromosome misalignments during
mitosis. Numbers (#) and percentages (%) of cells with
misalignments, such as centrophilic chromosomes, anaphase
bridges and lagging chromosomes are listed.
(DOC)
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